SLU-PP-332 is a synthetic small-molecule research compound developed to study exercise-mimetic signaling pathways. In preclinical research, it has been investigated for its ability to activate estrogen-related receptor (ERR) signaling, a key regulator of mitochondrial biogenesis, oxidative metabolism, and endurance-related cellular pathways.
Unlike peptide-based compounds, SLU-PP-332 is of interest for its role in energy metabolism and skeletal muscle adaptation models without direct physical exercise stimuli.
Research Focus
SLU-PP-332 is commonly explored in laboratory research involving:
- Mitochondrial biogenesis and oxidative metabolism
- Skeletal muscle endurance and fatigue resistance models
- ERRα / ERRγ signaling pathway studies
- Energy expenditure and metabolic efficiency research
- Exercise-mimetic and longevity-related signaling models
Research-Observed Effects
Preclinical studies suggest SLU-PP-332 may support:
- Enhanced mitochondrial oxidative capacity
- Activation of endurance-associated gene expression
- Improved metabolic efficiency in muscle tissue models
Findings are based on laboratory and experimental research only.
Product Specifications
- Compound:
SLU-PP-332 - Type:
Synthetic small-molecule research compound - Target Pathway:
Estrogen-Related Receptors (ERRs) - CAS Number:
Not publicly standardized - Purity:
≥99% (Analytical Verified) - Form:
Powder
Quality & Compliance
- Analytical purity verified
- Manufactured under controlled laboratory conditions
- For Research Use Only (RUO)
- Not for human or veterinary use
⚠️ This product is intended strictly for research purposes only and is not approved for human or veterinary use.